title: Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment.
authors.forename: M
authors.initials: M
authors.lastname: Cazzola
authors.forename: R
authors.initials: R
authors.lastname: Guarnone
authors.forename: P
authors.initials: P
authors.lastname: Cerani
authors.forename: A
authors.initials: A
authors.lastname: Rovati
authors.forename: E
authors.initials: E
authors.lastname: Ascari
mesh_terms: D000241:Adenosine / Q000502:physiology; D000293:Adolescent; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000097:blood* / Q000502:physiology; D005260:Female; D006801:Humans; D011086:Polycythemia / Q000097:blood / Q000151:congenital / Q000188:drug therapy*; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1 / Q000502:physiology; D011990:Receptors, Transferrin / Q000097:blood*; D015290:Second Messenger Systems / Q000187:drug effects / Q000502:physiology; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D011990:Receptors, Transferrin; D004921:Erythropoietin; D013806:Theophylline; D000241:Adenosine